13D Filing: Broadfin Capital and Recro Pharma Inc. (REPH)

Page 9 of 10

Page 9 of 10 – SEC Filing

Exhibit A

AGREEMENT

The undersigned agree that
this Schedule 13D/A, dated December 14, 2017, relating to the Common Stock par value $0.01 of Recro Pharma, Inc. shall be filed
on behalf of the undersigned.

December 14, 2017
(Date)
BROADFIN CAPITAL, LLC
By:  /s/ Kevin Kotler
Kevin Kotler, Managing Member
KEVIN KOTLER
/s/ Kevin Kotler
BROADFIN HEALTHCARE MASTER FUND, LTD.
By:  /s/ Kevin Kotler
Kevin Kotler, Director

Follow Societal Cdmo Inc. (NASDAQ:SCTL)

Page 9 of 10